MoneyWorks4Me

Earum Pharmaceutical - Quaterly Results

11 Jan 2022 Evaluate
The topline surged 76.30% to Rs. 48.87 millions for the December 2021 quarter as against Rs. 27.72 millions during the corresponding quarter last year.The Total Profit for the quarter ended December 2021 of Rs. 9.54 millions grew from Rs.-3.31 millions Operating profit Margin for the quarter ended December 2021 improved to 9.89% as compared to -1.05% of corresponding quarter ended December 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 48.87 27.72 76.30 133.10 118.80 12.04 410.84 551.09 -25.45
Other Income 0.00 33.28 0.00 22.00 41.37 -46.82 87.66 22.73 285.66
PBIDT 9.89 -1.05 -1041.90 64.48 -6.27 -1128.39 10.05 35.11 -71.38
Interest 0.00 2.26 0.00 0.10 6.91 -98.55 9.31 9.66 -3.62
PBDT 9.89 -3.31 -398.79 64.38 -13.18 -588.47 0.74 25.45 -97.09
Depreciation 0.35 0.00 0.00 0.85 0.00 0.00 1.23 1.00 23.00
PBT 9.54 -3.31 -388.22 63.53 -13.18 -582.02 -0.49 24.45 -102.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.30 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 9.54 -3.31 -388.22 63.53 -13.18 -582.02 -0.49 18.15 -102.70
Equity 123.36 61.68 100.00 123.36 61.68 100.00 61.68 61.68 0.00
PBIDTM(%) 20.24 -3.79 -634.26 48.44 -5.28 -1017.90 2.45 6.37 -61.60
Peers